Search the Newsreel

Colgate-Palmolive (NYSE: CL) director exercises options, sells 4,170 shares

Colgate-Palmolive director John T. Cahill exercised stock options for 4,170 shares at $71.56 per share and simultaneously sold these 4,170 shares at a weighted average price of $93.3712 to $93.39 on August 6, 2026. A portion of the proceeds covered the exercise price. After …

Cómo están reaccionando los inversores ante la reafirmación de las previsiones de Colgate-Palmolive (CL) en un contexto de aumento de las ventas y descenso de los beneficios

Wie Investoren auf die Bestätigung der Prognose durch Colgate-Palmolive (CL) angesichts höherer Umsätze und geringerer Gewinne reagieren

How Investors Are Reacting To Colgate-Palmolive (CL) Reaffirming Guidance Amid Higher Sales And Lower Profit

Colgate-Palmolive (CL) reported higher sales but lower net income in Q2 2026 compared to the previous year. Despite softer profitability, the company reaffirmed its full-year 2026 guidance for net sales growth of 2% to 6% and double-digit GAAP EPS growth. This article examines the …

Projeções de Resultados: Colgate-Palmolive Co (CL) — LPA e Crescimento de Receita

Colgate-Palmolive Co (CL) Aktuelle Aktien-News

Colgate-Palmolive (NYSE:CL) Director John Cahill Sells 4,170 Shares

Colgate-Palmolive Director John Cahill sold 4,170 shares of the company's stock for approximately $389,353, reducing his ownership by 12.81%. The company recently reported strong quarterly earnings, beating estimates with $0.99 EPS and revenue of $5.36 billion, and declared a quarterly dividend of $0.53. Analysts …

Autoliv Inc (ALV) Earnings Forecast: Future EPS & Revenue Growth Estimates

Autoliv Inc (ALV) has an earnings forecast score of 7.80, ranking 26th in the Automobiles & Auto Parts industry, with an average price target of $140.00 from 20 analysts. The stock is predominantly rated as "Buy," with expected revenue of $2.72 billion for the …

Colgate Palmolive Insider Sold Shares Worth $389,358, According to a Recent SEC Filing

An insider at Colgate Palmolive sold shares valued at $389,358, as per a recent SEC filing. This transaction was reported on August 7, 2026, though specific details of the insider or the nature of the sale were reserved for members of the platform. The …

Engaging In Options Activity, Noel Wallace Exercises Options Valued At $6.69M In Colgate-Palmolive

Colgate-Palmolive Chairman Noel Wallace exercised stock options for 322,042 shares, valued at $6.69 million, according to a recent SEC filing. The company's financials show positive revenue growth but slower growth compared to industry peers, and its EPS lags the industry average. Colgate-Palmolive maintains a …

Sarasin & Partners LLP Cuts Stock Position in Colgate-Palmolive Company $CL

Sarasin & Partners LLP reduced its holdings in Colgate-Palmolive Company by 25.6% in the second quarter, selling 639,036 shares but still retaining a significant stake worth $170.3 million. Despite this, institutional investors collectively own over 80% of the company. Colgate-Palmolive exceeded earnings expectations with …

Assenagon Asset Management S.A. Boosts Stock Position in Colgate-Palmolive Company $CL

Assenagon Asset Management S.A. significantly increased its stake in Colgate-Palmolive Company, boosting its holdings by 139.2% in the second quarter. This move makes the firm own approximately 0.21% of Colgate-Palmolive's stock, valued at over $155 million. Other institutional investors also adjusted their positions in …

Should Colgate-Palmolive (CL) Look Fully Valued After Q2 Results And Steady Guidance?

Colgate-Palmolive (NYSE:CL) CEO Sells $14,801,050.32 in Stock

Colgate-Palmolive CEO Noel Wallace sold 161,021 shares of company stock worth approximately $14.8 million. The sale was made to cover tax obligations on vested equity awards, reducing his direct ownership by 30.77%. The company recently reported strong quarterly earnings, beating estimates, and declared a …

COLGATE PALMOLIVE CO SEC Filing (Aug 6, 2026)

This article details a Form 144 SEC filing by Colgate-Palmolive (CL) on August 6, 2026. The filing indicates a proposed sale of 4,170 common shares acquired through the exercise of employee stock options, with an aggregate market value of $389,357.94, to be sold via …

Autoliv (NYSE:ALV) Stands Out for Dividend Quality

14,190 Shares in Colgate-Palmolive Company $CL Purchased by Canandaigua National Bank & Trust Co.

Canandaigua National Bank & Trust Co. recently acquired 14,190 shares of Colgate-Palmolive Company (NYSE:CL) worth approximately $1.3 million. This purchase is part of broader institutional interest, with analysts rating CL as a "Moderate Buy" and setting an average price target of $99. Colgate-Palmolive has …

Janus Henderson Group PLC Purchases 64,455 Shares of Colgate-Palmolive Company $CL

Janus Henderson Group PLC significantly increased its stake in Colgate-Palmolive Company by 108.1% in the first quarter, purchasing 64,455 additional shares, bringing its total holdings to 124,079 shares valued at $10.6 million. The company reported strong Q1 earnings, beating estimates with EPS of $0.99 …

Colgate-Palmolive Q2 GJ 2026: Bruttomarge steigt, GAAP-EPS sinkt

Colgate-Palmolive Readies Organization for Agentic Future

Colgate-Palmolive is undergoing a global digital transformation, heavily investing in AI, data, and analytics to create an "agentic future." CEO Noel Wallace detailed efforts to build an internal AI hub, develop data products, and redesign processes with embedded agents to enhance productivity and optimize …

Groupama Asset Managment Cuts Stock Holdings in Colgate-Palmolive Company $CL

Groupama Asset Management significantly reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 90.5% in the first quarter, selling 23,585 shares and retaining 2,464. Despite this, institutional investors collectively own a substantial 80.41% of the company, and analysts maintain a "Moderate Buy" consensus rating with …

Pacer Advisors Inc. Has $29.86 Million Holdings in Autoliv, Inc. $ALV

Pacer Advisors Inc. significantly increased its stake in Autoliv, Inc. (NYSE:ALV) by 3,296.4% in the first quarter, now holding 283,973 shares valued at $29.86 million, representing about 0.38% of the company. Autoliv maintains a "Moderate Buy" consensus rating from analysts with an average price …

Edgestream Partners L.P. Has $1.70 Million Holdings in Colgate-Palmolive Company $CL

Edgestream Partners L.P. significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 131% in the first quarter, now holding 19,924 shares valued at approximately $1.70 million. Institutional investors collectively own 80.41% of the company, which recently reported strong quarterly earnings of $0.99 EPS and …

Confluence Investment Management LLC Decreases Stock Holdings in Colgate-Palmolive Company $CL

Confluence Investment Management LLC reduced its stake in Colgate-Palmolive Company (NYSE:CL) by 3.3% in the second quarter, now holding 1,209,372 shares worth $110.875 million, making it their 18th largest position. Despite this decrease, other institutional investors like Norges Bank and Bank of New York …

Colgate Palmolive (India) shares decline 2.07%

Colgate-Palmolive’s Q2 Earnings Beat on Nearly Every Line But Free Cash Flow Stole the Show.

JPMorgan Chase & Co. Lowers Colgate-Palmolive (NYSE:CL) Price Target to $103.00

JPMorgan Chase & Co. has reduced its price target for Colgate-Palmolive (NYSE:CL) from $104.00 to $103.00, while maintaining an "overweight" rating. This new price target suggests a potential upside of 12.76% from the company's previous closing price. Other analysts have also recently updated their …

RBC Capital raises Colgate-Palmolive stock price target on profit execution

RBC Capital increased its price target for Colgate-Palmolive (NYSE:CL) to $104 from $102, maintaining an Outperform rating due to strong profit execution despite mixed quarterly results. The company's gross profit margin of 60.43% was highlighted as a key strength, alongside an EPS beat driven …

TD Cowen raises Colgate-Palmolive stock price target on margin beat

TD Cowen has increased its price target for Colgate-Palmolive (NYSE:CL) stock to $90 from $

UBS Adjusts Price Target on Colgate-Palmolive to $109 From $106, Maintains Buy Rating

UBS has increased its price target for Colgate-Palmolive (CL) to $109 from $106, while maintaining a Buy rating on the stock. This adjustment comes amidst several other analyst revisions for Colgate-Palmolive on the same day, with most firms raising their price targets and maintaining …

Colgate Reports Strong Second Quarter 2026 Results

Colgate-Palmolive announced strong second-quarter 2026 financial results, with net sales increasing by 4.9% to $5.36 billion and adjusted earnings per share exceeding analyst expectations. The company saw regional growth in Latin America, Europe, the Middle East, Africa, and Asia-Pacific, while North America experienced a …

Colgate-Palmolive Company (CL) PT Raised to $90 at TD Cowen

TD Cowen analyst Robert Moskow has increased the price target for Colgate-Palmolive Company (NYSE: CL) to $90.00 from $85.00. This update indicates a positive outlook from the analyst for the consumer products giant. The article provides this key analyst action without further details, as …

RBC Capital Adjusts Colgate-Palmolive PT to $104 From $102, Maintains Outperform Rating

RBC Capital has increased its price target for Colgate-Palmolive (CL) to $104 from $102, while reiterating an Outperform rating on the stock. This adjustment comes amidst a series of analyst recommendations for Colgate-Palmolive, with several firms updating their price targets and ratings. The company …

Colgate-Palmolive Company $CL Shares Sold by Pacer Advisors Inc.

Pacer Advisors Inc. reduced its stake in Colgate-Palmolive (NYSE:CL) by 5.7% in the first quarter, selling 148,594 shares but still retaining over 2.45 million shares valued at approximately $208.9 million. This comes as Colgate-Palmolive reported strong second-quarter adjusted EPS and revenue growth, though GAAP …

Jefferies raises Colgate-Palmolive stock price target on emerging markets strength

Jefferies has increased its price target for Colgate-Palmolive (NYSE:CL) to $89 from $88, citing strong performance in emerging markets. Despite a "Hold" rating, the firm acknowledges Colgate-Palmolive as a prime way to access emerging market growth within U.S. household and personal care equities. However, …

Morgan Stanley Adjusts PT on Colgate-Palmolive to $104 From $100, Maintain Overweight Rating

Morgan Stanley has increased its price target on Colgate-Palmolive (CL) to $104 from $100, while maintaining an "Overweight" rating on the stock. This adjustment comes after Colgate-Palmolive reported its Q2 2026 earnings, with the company also reaffirming its annual sales forecast and updating its …